Fig. 1: Considerations and treatment options after second-generation TKI resistance.
aPonatinib dose based on comorbidities and mutation profile.
Fig. 1: Considerations and treatment options after second-generation TKI resistance. | Leukemia
aPonatinib dose based on comorbidities and mutation profile.
